Content Tagged “Michael Haller”
Published: Oct 18th, 2015
UFDI investigators and collaborators found that granulocyte colony stimulating factor monotherapy did not affect C-peptide production, HbA1c, or insulin dose.This study supports the continued exploration of G-CSF and other mobilizing […]
Published: Sep 28th, 2015
Dr. Haller currently serves as the Principal Investigator for the TrialNet ATG/GCSF study funded collaboratively by the NIH, the Helmsley Trust, and Sanofi.
Published: Sep 25th, 2015
Giovanna Beauchamp, M.D. and Michael J. Haller, M.D., M.S. recently released a review of several type 1 diabetes (T1D) prevention studies in Current Diabetes Reports. The publication, titled ‘Can We […]
Published: Sep 25th, 2015
Several studies have documented reduced incidence of diabetic ketoacidosis (DKA) in new-onset T1D when high-risk children are identified at an early age. As a result, researchers have questioned whether T1D […]
Published: Sep 24th, 2015
UF researchers are seeking to determine differences in pancreatic volume between new-onset Type 1 Diabetes (T1D) patients, antibody positive subjects at increased risk for T1D, and healthy controls. The study […]
Published: Sep 13th, 2015
UFDI faculty and a University of Miami researcher found that “reduced pancreas weight allows for comparisons across a wide range of donor ages by eliminating confounding variables.”
Published: Feb 18th, 2015
Results from a UF Health pilot study have led to a new national trial investigating a combination treatment for individuals newly diagnosed with Type 1 diabetes.
Published: Jul 11th, 2014
Several studies to date have found that people with type 1 diabetes (T1D) tend to have celiac disease more often than individuals in the general population. Michael Haller, MD, a pediatric endocrinologist at UF Health, told Medscape Medical News in a recent interview that screening every type 1 diabetes patient for the disease presents a unique clinical challenge.
Published: Jun 21st, 2014
UF and UF Health faculty, postdoctoral fellows, and graduate students submitted a record number of original research presentations for the American Diabetes Association’s 74th Scientific Sessions held June 13-17, 2014 at the Moscone Center in San Francisco, California. This year’s submissions represent one of the largest showcases of research emanating from UF.
Published: Jun 17th, 2014
Combining two different medications could help patients with Type 1 diabetes at least partially regain the ability to produce their own insulin, according to UF Health pediatric endocrinologist Michael Haller, MD.